|1.||Khaw, Kay-Tee: 3 articles (10/2008 - 05/2004)|
|2.||Shimazu, Taichi: 2 articles (03/2015 - 03/2011)|
|3.||Iwasaki, Motoki: 2 articles (03/2015 - 03/2011)|
|4.||Sawada, Norie: 2 articles (03/2015 - 03/2011)|
|5.||Sasazuki, Shizuka: 2 articles (03/2015 - 03/2011)|
|6.||Yamaji, Taiki: 2 articles (03/2015 - 03/2011)|
|7.||Tsugane, Shoichiro: 2 articles (03/2015 - 03/2011)|
|8.||Inoue, Manami: 2 articles (03/2015 - 03/2011)|
|9.||Saito, Shigeyuki: 2 articles (01/2015 - 01/2014)|
|10.||Ohnishi, Hirofumi: 2 articles (01/2015 - 01/2014)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2015 - "Inhibitory effects of O-methylated isoflavone glycitein on human breast cancer SKBR-3 cells."
11/01/2001 - "A variety of health benefits, including protection against breast cancer, have been attributed to soy food consumption, primarily because of the soybean isoflavones (genistein, daidzein, glycitein). "
09/01/2010 - "To identify safe and effective phytoestrogen candidates for HRT and breast cancer prevention, we investigated the effects of daidzein, genistein, coumestrol, resveratrol and glycitein on cell growth, cell cycle, cyclin D1 expression, apoptosis, Bcl-2/Bax expression ratio and p53-dependent or NF-kappaB-dependent transcriptional activity in MCF-7 breast cancer cells. "
11/01/2004 - "In the present study, we compare the effect of soy isoflavones in the form of aglycones (genistein, daidzein and glycitein) and glucosides (genistin, daidzin and glycitin) on the behavior of highly invasive breast cancer cells. "
06/28/2013 - "In the present paper, we describe the creation of a dietary analysis database (based on Dietplan6) for the determination of dietary intakes of specific PE (daidzein, genistein, glycitein, formononetin, biochanin A, coumestrol, matairesinol and secoisolariciresinol), in a group of women previously diagnosed and treated for postmenopausal breast cancer. "
|2.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2015 - "A significant reduction in ovarian cancer risk was also observed for the high tertile of serum glycitein level versus the low (Ptrend=0.005). "
01/01/2015 - "Decreased serum isoflavones levels, such as those for daidzein and glycitein, decreased serum adiponectin levels, and increased serum insulin levels could be shown to be associated with elevated risk of ovarian cancer."
05/01/2006 - "As part of their preclinical development for cancer prevention, PTI G-2535 (a soy isoflavone mixture containing 45% genistein, 23% daidzein, and 4% glycitein) and BBIC were evaluated for oncogenicity in p53((+/-)) mice. "
10/01/2001 - "Among these isoflavonoids, tectorigenin and genistein exhibited cytotoxicity against various human cancer cells; glycitein showed only mild cytotoxicity. "
10/01/2010 - "Following tumor establishment, mice were gavaged with vehicle or genistein or daidzein at 10 mg/kg body weight (BW) or a combination of genistein (10 mg/kg BW), daidzein (9 mg/kg BW), and glycitein (1 mg/kg BW) three times per week. "
01/01/2013 - "Risk estimates for breast cancers were adjusted ORs (95% CI) of 0.39 (0.23-0.66) and 0.31 (0.18-0.55) for daidzein, 0.35 (0.20-0.61) and 0.28 (0.16-0.52) for genistein, 0.66 (0.41-1.08) and 0.53 (0.32-0.88) for glycitein, and 0.53 (0.33-0.85) and 0.43 (0.26-0.71) for total isoflavone using hospital outpatient and population controls respectively. "
04/01/2007 - "It is composed predominantly of the isoflavones genistein, daidzein, and glycitein, which have anti-cancer properties. "
01/01/2015 - "Cell proliferation studies on the dietary phytoestrogen, glycitein against human breast carcinoma SKBR-3 cells showed that glycitein exhibits biphasic regulation on SKBR-3 cells. "
01/01/2015 - "Collective results showed that glycitein damaged the cell membranes by increasing membrane permeability and suggested possible mechanisms of the action of dietary phytoestrogens on human breast carcinoma SKBR-3 cells. "
|5.||NF-kappa B (NF-kB)